Login / Signup

Alterations in whole-body arginine metabolism in chronic obstructive pulmonary disease.

Renate JonkerNicolaas E P DeutzMarcia L ErblandPaula J AndersonMarielle P K J Engelen
Published in: The American journal of clinical nutrition (2016)
In stable patients with moderate-to-severe COPD, endogenous arginine production is upregulated to support a higher arginine utilization that is unrelated to whole-body NO production. This trial was registered at clinicaltrials.gov as NCT01173354 and NCT01172314.
Keyphrases
  • nitric oxide
  • chronic obstructive pulmonary disease
  • amino acid
  • clinical trial
  • study protocol
  • high intensity
  • early onset
  • phase iii
  • lung function
  • phase ii
  • cord blood
  • drug induced